Home/Filings/SCHEDULE 13G/0002096075-25-000001
SCHEDULE 13G//SEC Filing

Theriva Biologics, Inc. SCHEDULE 13G

Accession 0002096075-25-000001

CIK 0002096075other

Filed

Nov 9, 7:00 PM ET

Accepted

Nov 10, 6:03 PM ET

Size

163.7 KB

Accession

0002096075-25-000001

Issuer

Jeffrey Matthew Gryga Irrevocable Trust

CIK 0002096075

Entity typeother
IncorporatedAK

Related Parties

1
  • filerCIK 0002096075

Filing Metadata

Form type
SCHEDULE 13G
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 6:03 PM ET
Size
163.7 KB